127 GCGR knockout is detrimental in mice as 50% did not survive until birth in this study
Many of these nootropics have shown significant improvement in cognitive functions in various studies and randomized controlled trials
GSM-directed therapy in peri/postmenopausal patients (or others with hypo-oestrogen states): NICE and UK resources support vaginal oestrogen as a local therapy for genitourinary symptoms of menopause, with patient counselling that systemic absorption is minimal and serious adverse effects are very rare
Spiering BA, Kraemer WJ, Vingren JL, Hatfield DL, Fragal MS, Ho JY, Maresh CM, Anderson JM, Volek JS
These can include: Nausea or vomiting Constipation or diarrhea Fatigue or reduced appetite Rapid fat loss may cause hanging skin on the face and body (e.g., Ozempic face) To minimize discomfort, providers usually start at a low dose and slowly increase it